183 related articles for article (PubMed ID: 15989000)
1. [Experience in long-term therapy of active rheumatoid arthritis with leflunomide].
Chichasova NV; Igolkina EV; Brodetskaia KA; Imametdinova GR
Ter Arkh; 2005; 77(5):33-8. PubMed ID: 15989000
[TBL] [Abstract][Full Text] [Related]
2. [An antidestructive effect of leflunomide in early rheumatoid arthritis].
Balabanova RM; Kashevarov RIu; Oliunin IuA; Smirnov AV; Aleksandrova EN
Ter Arkh; 2006; 78(6):6-10. PubMed ID: 16881355
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
Wiacek R; Kolossa K; Jankowski T; Jeka S; Karmowski A; Karmowski M; Gworys B
Adv Clin Exp Med; 2012; 21(3):337-42. PubMed ID: 23214197
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide: a review of its use in active rheumatoid arthritis.
Prakash A; Jarvis B
Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
Goldenberg MM
Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide in the treatment of refractory rheumatoid arthritis.
Kuzmanova SI; Solakov PT; Batalov AZ; Staikova ND; Andreev SA; Russafov PB
Folia Med (Plovdiv); 2003; 45(3):43-7. PubMed ID: 15366665
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis.
Alldred A; Emery P
Expert Opin Pharmacother; 2001 Jan; 2(1):125-37. PubMed ID: 11336574
[TBL] [Abstract][Full Text] [Related]
8. [Leflunomide as a second choice treatment in patients with rheumatoid arthritis].
Raczkiewicz-Papierska A; Dudek A; Bachta A; Tłustochowicz M; Zawadyl B; Sułek M
Pol Merkur Lekarski; 2007 Jun; 22(132):547-50. PubMed ID: 17874627
[TBL] [Abstract][Full Text] [Related]
9. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.
Larsen A; Kvien TK; Schattenkirchner M; Rau R; Scott DL; Smolen JS; Rozman B; Westhovens R; Tikly M; Oed C; Rosenburg R;
Scand J Rheumatol; 2001; 30(3):135-42. PubMed ID: 11469522
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of leflunomide in active rheumatoid arthritis.
Smolen JS; Emery P
Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
[TBL] [Abstract][Full Text] [Related]
13. [Development and/or increase of rheumatoid nodules in RA patients following leflunomide therapy].
Braun MG; Van Rhee R; Becker-Capeller D
Z Rheumatol; 2004 Feb; 63(1):84-7. PubMed ID: 14991281
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of rheumatoid arthritis activity in clinical practice].
Oliunin IuA; Balabanova RM
Ter Arkh; 2005; 77(5):23-6. PubMed ID: 15988997
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide: long-term clinical experience and new uses.
Kaltwasser JP; Behrens F
Expert Opin Pharmacother; 2005 May; 6(5):787-801. PubMed ID: 15934905
[TBL] [Abstract][Full Text] [Related]
16. [Leflunomide in the treatment of rheumatoid arthritis].
Kochbati S; Ben Miled M; Boussema F; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
Tunis Med; 2005 Feb; 83(2):91-7. PubMed ID: 15969231
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
18. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
[TBL] [Abstract][Full Text] [Related]
19. [Changes in indices of inflammatory activity in patients with rheumatoid arthritis during early stages of basic therapy with leflunomide].
Balabanova RM; Makolkin VI; Shostak NA; Chichasova NV; Oliunin IuA; Goriachev DV; Loginova TK; Riabkova AA; Petukhova NV; Men'shikova IV
Ter Arkh; 2004; 76(5):28-32. PubMed ID: 15230128
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.
Alivernini S; Mazzotta D; Zoli A; Ferraccioli G
Drugs Aging; 2009; 26(5):395-402. PubMed ID: 19552491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
